CCO Independent Conference Coverage

2008 Annual Meeting of the European Association for the Study of the Liver*

April 23-27, 2008 | Milan, Italy

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on Hepatitis B Management

Track 1 of 4

Faculty:
	Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF Patrick Marcellin, MD Norah Terrault, MD, MPH

Focus on Investigational HCV Agents

Track 2 of 4

Faculty:
	Nezam H. Afdhal, MD, FRCPI Ira M. Jacobson, MD Stefan Zeuzem, MD

New Advances in Hepatitis C

Track 3 of 4

Capsule Summaries

Expert Analysis

Faculty:
	Alfredo Alberti, MD Peter Ferenci, MD Michael P. Manns, MD

Highlight on Special Hepatic Issues and Populations

Track 4 of 4

Capsule Summaries

Expert Analysis

Faculty:
	Robert G. Gish, MD Josep M. Llovet, MD Paul Martin, MD

Expert Highlights

Michael P. Manns, MD, highlights the clinical implications of trials performed in hepatitis C nonresponders and relapsers as well as results from a late-breaker presentation comparing the 2 available formulations of peginterferon. (9 minutes)

Download Audio

Stefan Zeuzem, MD, highlights data from EASL 2008 on 2 of the most clinically advanced classes of investigational hepatitis C agents—protease inhibitors and nucleoside polymerase inhibitors. (7 minutes)

Download Audio

Maria Buti-Ferret, MD, discusses key efficacy and resistance HBV data presented at the meeting in Milan, including reports in treatment-naive patients and strategies for patients with resistance. (12 minutes)

Download Audio

Robert G. Gish, MD, discusses key presentations on insulin resistance, portal hypertension and cirrhosis, approved and investigational treatments for HCC, liver transplantation, and treatment of autoimmune hepatitis. (10 minutes)

Download Audio

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.